Instrument Inactif

Autres langues Liminal BioSciences Inc.

Actions

PJ2

CA53272L2021

Recherche biotechnologique et médicale

Autres langues

26/09/23	Liminal BioSciences : Notice
26/09/23	Liminal BioSciences Inc.(NasdaqCM:LMNL) dropped from NASDAQ Composite Index
26/09/23	Structured Alpha LP, a fund managed by Thomvest Ventures, Inc. completed the acquisition of remaining 38.8% stake in Liminal BioSciences Inc. (DB:PJ2).
12/09/23	Liminal BioSciences : Supplement to the Arrangement Circular – Special Meeting September 2023
17/08/23	Liminal BioSciences : Notice of Special Meeting of Shareholders and Management Information Circular dated August 16, 2023 - Form 6-K
17/08/23	Liminal BioSciences : Form of Proxy – Special Meeting September 2023
17/08/23	Liminal BioSciences : Other
16/08/23	Liminal BioSciences : Letter of Transmittal – Special Meeting September 2023
16/08/23	Liminal BioSciences : Notice of Special Meeting - Special Meeting September 2023
16/08/23	Liminal BioSciences : Arrangement Circular – Special Meeting September 2023
16/08/23	LIMINAL BIOSCIENCES OBTAINS INTERIM ORDER FOR PROPOSED ARRANGEMENT WITH STRUCTURED ALPHA LP
16/08/23	Liminal BioSciences : Other
16/08/23	Liminal BioSciences : Form of proxy - English
08/08/23	Liminal BioSciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
08/08/23	Liminal BioSciences : 52-109F2 - Certification of interim filings - CEO (E)
08/08/23	Liminal BioSciences : 52-109F2 - Certification of interim filings - CFO (E)
08/08/23	Liminal BioSciences : Annual MD&A - English
08/08/23	Liminal BioSciences : Interim financial statements/report - English
08/08/23	Liminal BioSciences : News release - English
02/08/23	Liminal BioSciences : Notice of the meeting and record date - English
12/07/23	Top Midday Gainers
12/07/23	Liminal BioSciences Agrees to Be Acquired by Structured Alpha for $8.50 per Share; Shares Soar Pre-Bell
05/06/23	Liminal BioSciences Provides R&D Update
02/06/23	Liminal BioSciences Provides R&D Update
09/05/23	Liminal BioSciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023